Abstract: Abstract Topical antiaging therapies provide noninvasive delivery of active therapeutics
The effect of TZDs on kidney function has been previously described in mice models ( Another interesting class of hypoglycemic drugs with positive kidney outcomes are the SGLT2 inhibitors (SGLT2i) which inhibit glucose and sodium reabsorption in the PT (Williams et al., 2020)
Eli Lilly makes both the dual-agonist and triple-agonist drugs
However, they are believed to be genetic (Nath et al., 1994
Igosheva N et al (2010) Maternal diet-induced obesity alters mitochondrial activity and redox status in mouse oocytes and zygotes
Mancini MC, Morelli AP, Severino MB, Pavan IC, Zambalde P, Gis MM, et al